$46.43
▲ $6.51 (+16.3%)
URGN
UroGen Pharma Ltd. Ordinary Shares
Health Care
Investor Score
55C
Moderate rating
Based on 7 of 7 weighted categories, computed from real, live financial data only.
75
Technical
51
Fundamental
40
Growth
38
Fair Value
50
News
63
Quality
54
Risk
Want the full breakdown — DCF fair value, technical indicators, news sentiment, and an AI-written narrative explaining this score?
View the full analysis (Hebrew) ←All raw data comes from real commercial financial data providers. This page is for educational purposes only and is not investment advice.